Anthropic establishes biological laboratory for pharmaceutical research

Anthropic has launched its own biological laboratory to integrate its Claude AI models with physical experiments, robotics, and preclinical drug development. The initiative aims to accelerate treatments for underserved diseases. The company now faces the challenge of demonstrating that AI-driven automation can enhance productivity while effectively managing biological risks.